What is CLPT's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.32B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CLPT?

P/E (TTM) is n/a and 52-week range is $8.27 to $30.10 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CLPT figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CLPT?

The company profile lists revenue (TTM) near $42M, net income (TTM) near $-3.44B, EPS (TTM) near $-1.18 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Clearpoint Neuro Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Solana Beach, California, US, 30M shares outstanding, ISIN US18507C1036 when available from company profile and filing metadata.

Clearpoint Neuro Inc

$CLPT

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$10.48

-0.10%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

ClearPoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 172 full-time employees. The company went IPO on 2019-07-03. The company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The company provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. The company also offers IRRAflow active fluid-exchange system.

Employees

172

Website

www.clearpointneuro.com/

IPO

2019-07-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)